Rendón-Tarin BI, Calzada-Pérez MA, Rodríguez-Wong U

Language: Spanish
References: 11
Page: 235-238
PDF size: 136.52 Kb.

ABSTRACT

Ocular manifestations may precede the diagnosis of chronic ulcerative colitis or Crohn’s disease. They are rare, and occur between 1.9 and 11.8% of cases, and it is for this reason that often goes unnoticed; however are associated with high morbidity and may even cause blindness. The most frequent ocular manifestations of inflammatory bowel disease are episcleritis, scleritis and uveitis, among others. The eye examination should be performed in all patients with inflammatory bowel disease to detect early these manifestations.

REFERENCES

1. Calvo P, Pablo L. Managing IBD outside the gut: ocular manifestations. Dig Dis 2013; 31(2): 229-32.

2. Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med 2010; 42(2): 97-114.

3. Foster C, Vitale A. Idiopathic inflammatory bowel diseaseassociated Arthrtis. In: Diagnosis and treatment of uveitis. Cap. 54. 2a. Ed. 2013, p. 803-5.

4. Mintz R, Feller ER, Bahr RL, Shah SA. Ocular manifestations of inflammatory bowel disease. Ocular manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2004; 10(2): 135-9.

5. Cury DB, Moss AC. Ocular manifestations in a communitybased cohort of patients with inflammatory bowel disease. Inflamm Bowel Dis 2010; 16(8): 1393-6.

6. Yilmaz S, Aydemir E, Maden A, Unsal B. The prevalence of ocular involvement in patients with inflammatory bowel disease. Int J Colrectal Dis 2007; 22(9): 1027-30.

7. Trikudanathan G, Venkatesh PG, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs 2012; 72(18): 2333-49.

8. Manganelli C, Turco S, Balestrazzi E. Ophthalmological aspects of IBD. Eur Rev Med Pharmacol Sci 2009; 13 (Suppl. 1): 11-3.

9. Abbasian J, Martin TM, Patel S, Tessler HH, Goldstein DA. Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease. Am J Ophthalmol 2012; 154(1): 72-7.

10. Suhler EB, Smith JR, Giles TR, Lauer AK, Wertheim MS, Kurz DE, et al. Infliximab therapy for refractory uveitis: 2- year results of a prospective trial. Arch Ophthalmol 2009; 127: 819-22.

11. Felekis T, Katsanos K, Kitsanou M, Trakos N, Theopistos V, Christodoulou D, Asproudis I, et al. Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study. Inflamm Bowel Dis 2009; 15(1): 29-34.